Penn Medicine researchers have identified a link between the use of GLP-1 medications and an increased, though muted, risk of hair loss. This finding comes as these drugs see wider adoption for various health conditions.
The study aimed to systematically investigate this potential side effect in real-world patients. Senior author Yong Chen emphasized the importance of this research, saying, "Given the widening use of these medications, we felt it was important to systematically examine this potential side effect in real-world patients."
This research from the University of Pennsylvania contributes to a growing understanding of the comprehensive effects of GLP-1s, providing valuable information for both healthcare providers and patients considering or currently using these medications.